Accellix Revenue and Competitors
Estimated Revenue & Valuation
- Accellix's estimated annual revenue is currently $16.9M per year.
- Accellix's estimated revenue per employee is $155,000
- Accellix's total funding is $19.5M.
Employee Data
- Accellix has 109 Employees.
- Accellix grew their employee count by 22% last year.
Accellix's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | VP Operations | Reveal Email/Phone |
5 | VP Sales & Marketing | Reveal Email/Phone |
6 | Head Sales - Europe | Reveal Email/Phone |
7 | VP Global Operations | Reveal Email/Phone |
8 | Director, Consumables Manufacturing/Quality Assurance | Reveal Email/Phone |
9 | Director Sales, North America | Reveal Email/Phone |
10 | Director QA&RA | Reveal Email/Phone |
Accellix Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Accellix?
Accellix aims to enable cell and gene therapy companies to meet their key product QC requirements by providing fast and actionable multi-parameter results using the Accellix instrument and a room temperature stable cartridge. Accellix will continue to identify markets where its platform and assay migration expertise can be best combined to create meaningful opportunities.
keywords:N/A$19.5M
Total Funding
109
Number of Employees
$16.9M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Accellix News
Accellix, a San Jose, CA and Jerusalem, Israel-based cell therapy QC company, raised $9.5M in Series D funding. The round was led by bioMérieux, with participation from existing major investors, who have also agreed to convert their pre-existing convertible note in the amount of $8.5m. This bro ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.8M | 109 | 14% | N/A |
#2 | $75M | 109 | 4% | N/A |
#3 | $29.4M | 109 | 25% | N/A |
#4 | $14.3M | 110 | -24% | $64.7M |
#5 | $16.8M | 110 | 24% | $14M |